Immunogenicity and Safety of Extended Dosing Intervals for Pfizer Pentavalent MenABCWY Meningococcal Vaccination in Healthy Adolescents: Results from a Randomized, Phase 2b Study.
Saved in:
| Title: | Immunogenicity and Safety of Extended Dosing Intervals for Pfizer Pentavalent MenABCWY Meningococcal Vaccination in Healthy Adolescents: Results from a Randomized, Phase 2b Study. |
|---|---|
| Authors: | Jones JC; Wasatch Pediatrics, Murray, UT 84107, USA., Tipton MD; CopperView Medical Center, South Jordan, UT 84095, USA., Zolotas L; Pfizer Vaccine Research and Development, Marlow SL7 1YL, UK., Maguire JD; Pfizer Vaccine Research and Development, Collegeville, PA 19426, USA., Belanger K; Pfizer Vaccine Research and Development, Pearl River, NY 10965, USA., Liu Y; Pfizer Vaccine Research and Development, Collegeville, PA 19426, USA., Maansson R; Pfizer Vaccine Research and Development, Collegeville, PA 19426, USA., O'Neill RE; Pfizer Vaccine Research and Development, Pearl River, NY 10965, USA., Balmer P; Pfizer US Vaccines Medical Affairs, Collegeville, PA 19426, USA., Peyrani P; Pfizer US Vaccines Medical Affairs, Collegeville, PA 19426, USA., Beeslaar J; Pfizer Vaccine Research and Development, Marlow SL7 1YL, UK. |
| Source: | Vaccines [Vaccines (Basel)] 2026 Apr 15; Vol. 14 (4). Date of Electronic Publication: 2026 Apr 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2076-393X |
|---|---|
| DOI: | 10.3390/vaccines14040352 |
